VHT holdings (2026)
All 401 positions in Vanguard Health Care ETF, ranked by portfolio weight — led by LLY at 13.0%. Weights come from the fund's own SEC N-PORT filing and update daily with prices; positions in stocks ChartRow doesn't track still appear, ranked by weight, without returns. Not investment advice.
Weights are the May 31, 2026 SEC filing rolled forward on each holding’s price move (as of market close, Oct 5, 2026) — an estimate of today, not the filed figure. Switch the table below to see them exactly as filed.
Top 10 holdings#
Sector weights#
Estimated portfolio characteristics#
Estimated by our own bottom-up analysis of the fund’s SEC-filed holdings, covering 93% of portfolio weight (91% carries a valid trailing P/E). Funds publish similar figures on their own sites; ours are recomputed daily from public data.
VHT holdings by weight
1–100 of 401| # | Company | Weight | Price | 1D | YTD | 1Y | Mkt cap |
|---|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly and Company | 13.01% | $1,144.09 | +0.11% | +6.37% | +36.11% | $1.02T |
| 2 | JNJJohnson & Johnson | 8.51% | $252.90 | -1.22% | +22.22% | +34.08% | $609B |
| 3 | ABBVAbbVie Inc. | 6.65% | $265.90 | +1.17% | +16.31% | +13.62% | $470B |
| 4 | MRKMerck & Co. Inc. | 4.90% | $139.54 | -3.30% | +32.57% | +56.45% | $344B |
| 5 | UNHUnitedHealth Group Incorporated Common Stock (DE) | 4.86% | $378.68 | +1.82% | +14.68% | +5.10% | $340B |
| 6 | TMOThermo Fisher Scientific Inc. | 3.60% | $676.65 | +3.34% | +16.79% | +24.56% | $250B |
| 7 | AMGNAmgen Inc. | 3.07% | $403.09 | +0.01% | +23.12% | +35.28% | $218B |
| 8 | GILDGilead Sciences Inc. | 2.54% | $144.66 | -0.06% | +17.83% | +28.34% | $179B |
| 9 | ABTAbbott Laboratories | 2.46% | $100.14 | +2.71% | -20.11% | -25.63% | $173B |
| 10 | PFEPfizer Inc. | 2.21% | $27.41 | -1.40% | +10.08% | +0.15% | $156B |
| 11 | ISRGIntuitive Surgical Inc. | 2.04% | $406.48 | +3.71% | -28.23% | -10.14% | $144B |
| 12 | DHRDanaher Corporation | 1.99% | $221.21 | +3.34% | -3.37% | +2.89% | $156B |
| 13 | VRTXVertex Pharmaceuticals Incorporated | 1.81% | $503.70 | -0.20% | +11.06% | +24.85% | $128B |
| 14 | BMYBristol-Myers Squibb Company | 1.70% | $58.80 | -3.84% | +9.03% | +29.39% | $120B |
| 15 | MCKMcKesson Corporation | 1.60% | $916.21 | +1.54% | +11.60% | +24.03% | $107B |
| 16 | MDTMedtronic plc. | 1.60% | $88.01 | +1.89% | -8.42% | -9.96% | $113B |
| 17 | CVSCVS Health Corporation | 1.56% | $87.01 | +0.64% | +9.64% | +12.29% | $111B |
| 18 | SYKStryker Corporation | 1.39% | $285.34 | +3.60% | -18.85% | -23.02% | $109B |
| 19 | ELVElevance Health Inc. | 1.21% | $394.47 | +2.08% | +12.54% | +12.56% | $86B |
| 20 | REGNRegeneron Pharmaceuticals Inc. | 1.06% | $726.84 | -1.14% | -5.88% | +21.08% | $75B |
| 21 | CIThe Cigna Group | 1.03% | $271.35 | +0.30% | -1.43% | -12.77% | $72B |
| 22 | HCAHCA Healthcare Inc. | 0.98% | $435.03 | +1.95% | -6.84% | +1.25% | $94B |
| 23 | BSXBoston Scientific Corporation | 0.89% | $42.39 | -0.49% | -55.53% | -56.43% | $61B |
| 24 | MRNAModerna Inc. | 0.87% | $203.21 | +6.95% | +589.08% | +613.27% | $81B |
| 25 | CORCencora Inc. | 0.82% | $315.05 | +1.94% | -6.76% | +4.02% | $60B |
| 26 | NTRANatera Inc. | 0.79% | $425.65 | +3.73% | +85.80% | +154.34% | $61B |
| 27 | CAHCardinal Health Inc. | 0.78% | $233.11 | +2.11% | +13.44% | +50.93% | $54B |
| 28 | BDXBecton Dickinson and Company | 0.73% | $180.68 | +2.19% | +18.42% | +18.70% | $49B |
| 29 | EWEdwards Lifesciences Corporation | 0.72% | $87.25 | +2.47% | +2.32% | +13.18% | $50B |
| 30 | HUMHumana Inc. | 0.69% | $404.50 | +4.16% | +57.76% | +42.42% | $49B |
| 31 | AAgilent Technologies Inc. | 0.69% | $171.30 | +2.10% | +25.88% | +20.93% | $48B |
| 32 | IQVIQVIA Holdings Inc. | 0.64% | $266.05 | +3.04% | +18.05% | +28.78% | $44B |
| 33 | ILMNIllumina Inc. | 0.64% | $293.94 | +7.65% | +123.92% | +187.59% | $44B |
| 34 | VEEVVeeva Systems Inc. | 0.63% | $283.47 | +3.71% | +26.98% | -4.33% | $46B |
| 35 | WATWaters Corporation | 0.61% | $440.20 | +3.53% | +15.87% | +34.02% | $43B |
| 36 | IDXXIDEXX Laboratories Inc. | 0.60% | $527.07 | +1.67% | -22.09% | -16.50% | $42B |
| 37 | DXCMDexCom Inc. | 0.48% | $86.96 | +1.87% | +30.93% | +29.60% | $33B |
| 38 | RVMDRevolution Medicines Inc. | 0.48% | $207.88 | +0.60% | +160.74% | +344.62% | $45B |
| 39 | BIIBBiogen Inc. | 0.46% | $223.38 | +1.59% | +27.05% | +39.85% | $33B |
| 40 | RMDResMed Inc. | 0.46% | $222.90 | +1.83% | -7.48% | -20.00% | $32B |
| 41 | CNCCentene Corporation | 0.45% | $64.31 | +2.10% | +56.26% | +66.15% | $32B |
| 42 | MTDMettler-Toledo International Inc. | 0.45% | $1,541.22 | +3.70% | +10.58% | +17.32% | $31B |
| 43 | ZTSZoetis Inc. | 0.45% | $71.42 | +2.48% | -43.24% | -51.23% | $30B |
| 44 | GEHCGE HealthCare Technologies Inc. Common Stock | 0.42% | $65.75 | +2.27% | -19.85% | -14.13% | $30B |
| 45 | ALNYAlnylam Pharmaceuticals Inc. | 0.41% | $220.02 | +0.14% | -44.70% | -51.82% | $29B |
| 46 | WSTWest Pharmaceutical Services Inc. | 0.38% | $376.77 | +3.23% | +36.93% | +38.23% | $27B |
| 47 | DGXQuest Diagnostics Incorporated | 0.37% | $232.07 | -0.54% | +33.82% | +29.49% | $26B |
| 48 | LHLabcorp Holdings Inc. | 0.36% | $308.52 | +0.01% | +23.03% | +11.45% | $25B |
| 49 | THCTenet Healthcare Corporation | 0.32% | $259.44 | +0.32% | +30.57% | +27.82% | $21B |
| 50 | INSMInsmed Incorporated | 0.31% | $103.88 | -6.52% | -40.34% | -33.93% | $23B |
| 51 | UTHRUnited Therapeutics Corporation | 0.31% | $536.66 | -0.93% | +10.09% | +18.39% | $23B |
| 52 | GHGuardant Health Inc. | 0.30% | $187.32 | +5.35% | +83.30% | +197.93% | $25B |
| 53 | STESTERIS plc (Ireland) | 0.29% | $211.09 | +1.22% | -16.74% | -12.96% | $21B |
| 54 | VTRSViatris Inc. | 0.29% | $17.62 | +0.09% | +41.53% | +72.91% | $20B |
| 55 | INCYIncyte Corp. | 0.27% | $114.14 | -1.01% | +15.55% | +31.41% | $23B |
| 56 | ZBHZimmer Biomet Holdings Inc. | 0.26% | $91.59 | +3.74% | +1.83% | -9.14% | $17B |
| 57 | RVTYRevvity Inc. | 0.25% | $157.41 | +3.88% | +62.65% | +67.32% | $18B |
| 58 | CRLCharles River Laboratories | 0.22% | $310.95 | +7.15% | +55.79% | +75.25% | $15B |
| 59 | EXELExelixis Inc. | 0.21% | $58.86 | +0.80% | +34.27% | +46.79% | $15B |
| 60 | NBIXNeurocrine Biosciences Inc. | 0.20% | $144.32 | +0.80% | +1.68% | +5.24% | $15B |
| 61 | MEDPMedpace Holdings Inc. | 0.20% | $620.64 | +3.53% | +10.48% | +16.53% | $17B |
| 62 | SOLVSolventum Corporation | 0.19% | $88.08 | +0.26% | +11.09% | +18.96% | $15B |
| 63 | Vanguard Cmt Funds-Vanguard Market Liquidity Fund | 0.19% | — | — | — | — | — |
| 64 | ROIVRoivant Sciences Ltd. | 0.19% | $35.81 | +0.25% | +64.88% | +121.27% | $26B |
| 65 | JAZZJazz Pharmaceuticals plc Common Stock (Ireland) | 0.18% | $236.10 | +0.18% | +38.85% | +69.23% | $15B |
| 66 | HALOHalozyme Therapeutics Inc. | 0.18% | $108.32 | -1.40% | +60.94% | +57.02% | $12B |
| 67 | BAXBaxter International | 0.18% | $24.22 | +3.11% | +26.74% | +1.51% | $13B |
| 68 | TWSTTwist Bioscience Corporation | 0.17% | $204.98 | +8.64% | +546.28% | +559.80% | $13B |
| 69 | EHCEncompass Health Corporation | 0.17% | $121.01 | +1.01% | +13.97% | -1.83% | $12B |
| 70 | PENPenumbra Inc. | 0.17% | $317.38 | -0.05% | +1.99% | +23.84% | $13B |
| 71 | Ionis Pharmaceuticals Inc | 0.17% | — | — | — | — | — |
| 72 | CORTCorcept Therapeutics Incorporated | 0.16% | $122.08 | +5.03% | +250.66% | +38.43% | $13B |
| 73 | TECHBio-Techne | 0.16% | $72.60 | +0.27% | +23.41% | +15.30% | $11B |
| 74 | ELANElanco Animal Health Incorporated | 0.16% | $22.51 | +1.67% | -0.53% | +9.06% | $11B |
| 75 | COOThe Cooper Companies Inc. | 0.16% | $56.76 | -0.26% | -30.73% | -19.43% | $11B |
| 76 | AVTRAvantor Inc. | 0.15% | $15.81 | +3.03% | +37.96% | +10.64% | $11B |
| 77 | BMRNBioMarin Pharmaceutical Inc. | 0.15% | $57.56 | +0.66% | -3.18% | +3.81% | $11B |
| 78 | TXG10x Genomics Inc. | 0.15% | $97.93 | +4.74% | +499.26% | +666.59% | $13B |
| 79 | ENSGThe Ensign Group Inc. | 0.14% | $172.87 | +0.63% | -0.75% | -1.43% | $10B |
| 80 | MOHMolina Healthcare Inc | 0.14% | $193.99 | +2.35% | +11.82% | -3.92% | $10B |
| 81 | UHSUniversal Health Services | 0.14% | $176.04 | +0.18% | -19.25% | -15.05% | $10B |
| 82 | ALGNAlign Technology Inc. | 0.14% | $140.61 | -2.18% | -9.93% | +6.42% | $10B |
| 83 | BBIOBridgeBio Pharma Inc. | 0.14% | $66.17 | -1.61% | -13.53% | +25.12% | $13B |
| 84 | PODDInsulet Corporation | 0.14% | $135.65 | +3.01% | -52.29% | -56.13% | $9B |
| 85 | GKOSGlaukos Corporation | 0.13% | $164.02 | +0.16% | +45.26% | +87.63% | $10B |
| 86 | MDLNMedline Inc. | 0.13% | $35.81 | +0.56% | -14.76% | — | $31B |
| 87 | BTSGBrightSpring Health Services Inc. | 0.13% | $62.01 | +2.92% | +65.55% | +118.62% | $12B |
| 88 | HSICHenry Schein | 0.13% | $84.25 | -0.74% | +11.44% | +25.66% | $9B |
| 89 | GMEDGlobus Medical Inc. | 0.12% | $76.59 | +1.31% | -12.30% | +26.60% | $10B |
| 90 | Masimo Corp | 0.12% | — | — | — | — | — |
| 91 | TEMTempus AI Inc. | 0.11% | $83.54 | +9.02% | +41.49% | -8.85% | $15B |
| 92 | ARWRArrowhead Pharmaceuticals Inc. | 0.11% | $62.37 | -2.84% | -6.09% | +72.62% | $9B |
| 93 | HealthEquity Inc | 0.11% | — | — | — | — | — |
| 94 | CYTKCytokinetics Incorporated | 0.10% | $62.75 | -4.34% | -1.32% | +10.06% | $8B |
| 95 | MDGLMadrigal Pharmaceuticals Inc. | 0.10% | $493.60 | -1.16% | -15.24% | +11.42% | $11B |
| 96 | KRYSKrystal Biotech Inc. | 0.10% | $335.08 | +3.97% | +35.82% | +82.62% | $10B |
| 97 | BIOBio-Rad Laboratories Inc. | 0.10% | $379.73 | +2.87% | +25.36% | +24.33% | $10B |
| 98 | DVADaVita Inc. | 0.10% | $178.70 | +0.01% | +57.31% | +36.26% | $11B |
| 99 | PRAXPraxis Precision Medicines Inc. | 0.09% | $284.00 | -3.90% | -3.79% | +421.44% | $8B |
| 100 | Repligen Corp | 0.09% | — | — | — | — | — |
Methodology#
Holdings and weights are sourced from the fund’s portfolio as disclosed to the SEC on Form N-PORT — a public filing. Portfolio filings are quarterly (public ~60 days after quarter end), so we anchor on the latest one and roll each weight forward daily by that holding’s price move, keeping the numbers current between filings; positions in stocks ChartRow doesn’t track carry their filed weight unchanged and show “—” where we have no data. Returns are total returns (dividends reinvested). One row per company, not per ticker: when a fund holds more than one share class of the same company (Alphabet’s GOOGL and GOOG, for example), we combine them into a single row whose weight is the sum of its classes. Past performance does not predict future returns; not investment advice.
FAQ#
- What are the top 10 holdings of VHT?
- VHT's top 10 holdings are Eli Lilly and Company (LLY), 13.0%; Johnson & Johnson (JNJ), 8.5%; AbbVie Inc. (ABBV), 6.6%; Merck & Co. Inc. (MRK), 4.9%; UnitedHealth Group Incorporated Common Stock (DE) (UNH), 4.9%; Thermo Fisher Scientific Inc. (TMO), 3.6%; Amgen Inc. (AMGN), 3.1%; Gilead Sciences Inc. (GILD), 2.5%; Abbott Laboratories (ABT), 2.5%; Pfizer Inc. (PFE), 2.2% — together about 52% of the fund, per its May 31, 2026 SEC filing with weights rolled forward to today.
- How many holdings does VHT have?
- Vanguard Health Care ETF (VHT) held 401 positions as of its latest SEC N-PORT filing (May 31, 2026).
- How current are VHT's holdings?
- Funds disclose their full portfolio to the SEC on Form N-PORT; the quarter-end report becomes public about 60 days later. ChartRow anchors on the latest public filing (May 31, 2026) and rolls each weight forward daily by that holding's price move, so the weights shown estimate today rather than the filing date.
- Is ChartRow affiliated with VHT or Vanguard?
- No. ChartRow is independent and is not affiliated with, sponsored by, or endorsed by Vanguard or Vanguard Health Care ETF. Everything on this page is derived independently from the fund's public SEC filings; fund names and trademarks belong to their owners. For information only — not investment advice.
